UBE2D3-mediated ubiquitination of ULK1 drives pathological mitophagy and cuproptosis in myocardial infarction
This study identifies UBE2D3 as a critical E2 ubiquitin-conjugating enzyme that drives pathological myocardial infarction by ubiquitinating ULK1 to trigger excessive mitophagy, which subsequently depletes mitochondrial cuproptosis effectors and cardiomyocytes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human heart is a relentless engine, beating roughly one hundred thousand times a day to keep blood flowing through the body. Because it works so hard and never truly rests, its cells are entirely dependent on tiny power plants called mitochondria to generate the energy needed for every contraction. When a heart attack occurs, blood flow is cut off, starving these cells of oxygen. In this desperate state, the cells attempt to survive by cleaning out their damaged power plants, a process known as mitophagy. Think of this as a factory worker removing broken machinery to keep the line running. However, if this cleaning process goes into overdrive, stripping away too many power plants, the cell collapses. A newer discovery in cell biology, called cuproptosis, describes a specific type of cell death triggered when copper builds up and causes essential proteins to clump together, shutting down the cell's energy production. For a long time, scientists have struggled to understand exactly how these two processes—the overzealous cleaning of mitochondria and the copper-induced shutdown—interact during a heart attack to kill heart muscle cells.
A team of researchers at the Naval Medical University and several affiliated hospitals in China has now uncovered a critical link between these events. By analyzing vast amounts of genetic data from heart attack patients and testing their findings in laboratory cell cultures, they identified a specific protein called UBE2D3 as the master switch that turns this survival mechanism into a lethal one. In a healthy heart, the cleaning of mitochondria is a controlled, helpful process. But in the oxygen-starved environment of a heart attack, the researchers found that UBE2D3 levels rise sharply. This protein acts like a tagger, attaching a molecular label to another protein called ULK1, which is the commander of the mitochondrial cleaning crew. This tagging tells the cell to start cleaning mitochondria at an accelerated, uncontrollable rate.
The study began by sifting through genetic records from heart attack patients to find which genes were most active during the injury. The researchers used computer algorithms to narrow down a list of candidates, eventually pinpointing UBE2D3 as a central hub that was significantly more active in damaged hearts than in healthy ones. They then moved to the laboratory, using rat cardiomyoblast cells (H9c2) grown in a dish to mimic the conditions of a heart attack. By placing these cells in an oxygen-deprived environment for three hours, they created a model of the injury. In these stressed cells, they observed that UBE2D3 levels increased, and the cells began to die at a much higher rate. When the researchers used a virus to silence the gene for UBE2D3, effectively turning it off, the cells survived the oxygen deprivation much better. The cells that lacked this protein did not lose their mitochondria as quickly, and their internal structures remained intact.
The researchers then investigated how UBE2D3 caused this damage. They discovered that UBE2D3 physically grabs onto the ULK1 protein and attaches a chain of ubiquitin molecules to it. In the language of cell biology, this ubiquitin chain acts as a signal that tells the cell to degrade or activate the target protein. In this case, the signal drove ULK1 to initiate a massive wave of mitochondrial removal. The cells essentially ate their own power plants faster than they could be replaced. This excessive cleaning led to a depletion of the mitochondria, leaving the cell without energy. Crucially, the team found that this process also wiped out the very machinery required for cuproptosis. Proteins like FDX1 and DLAT, which are necessary for the copper-induced cell death to occur, disappeared because the mitochondria they lived in were destroyed. This created a paradoxical situation: the cell was dying not because the copper mechanism was activated, but because the excessive cleaning had removed the tools needed for that specific type of death, leaving the cell vulnerable to other forms of failure.
To confirm that this chain of events was real, the scientists performed several detailed tests. They used a technique called co-immunoprecipitation to show that UBE2D3 and ULK1 physically bind to each other inside the cell. They also used a microscope to look at the cells' internal structures and saw that when UBE2D3 was active, the mitochondria were swollen and damaged, losing their normal shape. When they silenced UBE2D3, the mitochondria looked healthy and the cells survived. The study also measured the levels of specific proteins associated with cell death and found that blocking UBE2D3 restored the levels of the protective proteins that had been lost during the injury. The researchers concluded that UBE2D3 is not just a bystander but a driver of the damage, turning a protective cleaning process into a pathological one that exhausts the cell's energy reserves.
This work shifts the focus of heart attack research from the proteins that usually tag molecules for destruction to the enzymes that facilitate the tagging process itself. While previous studies often looked at the enzymes that do the final cutting, this team highlighted the role of the enzyme that prepares the tag. The findings suggest that in the context of a heart attack, the body's attempt to clean up damaged parts can backfire if the signal to clean is too strong. By identifying UBE2D3 as the source of this overactive signal, the researchers have pointed to a new potential target for treatment. If a drug could be developed to block UBE2D3, it might stop the heart cells from over-cleaning their mitochondria, preserving their energy and keeping them alive during a heart attack. The study was conducted using rat cardiomyoblast cells and computer models, so the results are a strong indication of what happens in the heart, but the researchers note that further work is needed to confirm if this same mechanism operates in human heart muscle cells in the same way. Nevertheless, the discovery provides a clear map of how a specific molecular switch can turn a survival mechanism into a fatal flaw, offering a new direction for protecting the heart when blood flow is cut off.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.